GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.560
+0.070 (1.56%)
At close: Aug 22, 2025, 4:00 PM
4.600
+0.040 (0.88%)
After-hours: Aug 22, 2025, 7:59 PM EDT
GoodRx Holdings Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$6.33
Upside
+38.82%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $6 → $5.25 | Hold | Maintains | $6 → $5.25 | +15.13% | May 13, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $6 → $5 | Hold | Maintains | $6 → $5 | +9.65% | May 9, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +53.51% | Apr 29, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $6.5 → $5.5 | Hold | Maintains | $6.5 → $5.5 | +20.61% | Apr 10, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $9 → $8 | Buy | Maintains | $9 → $8 | +75.44% | Feb 28, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $7 → $6.25 | Strong Buy | Maintains | $7 → $6.25 | +37.06% | Jan 10, 2025 |
| Keybanc | Keybanc | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +31.58% | Jan 8, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +31.58% | Dec 17, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $10 → $7 | Strong Buy | Maintains | $10 → $7 | +53.51% | Nov 13, 2024 |
| Barclays | Barclays | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +31.58% | Nov 11, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $10 | Buy | Reiterates | $10 | +119.30% | Aug 16, 2024 |
| UBS | UBS | Hold Maintains $9 → $8.5 | Hold | Maintains | $9 → $8.5 | +86.40% | Aug 9, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +119.30% | Aug 9, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $7 → $9.5 | Hold | Maintains | $7 → $9.5 | +108.33% | Jun 10, 2024 |
| RBC Capital | RBC Capital | Hold → Buy Upgrades $8 → $10 | Hold → Buy | Upgrades | $8 → $10 | +119.30% | May 23, 2024 |
| Barclays | Barclays | Buy Maintains $9 → $10 | Buy | Maintains | $9 → $10 | +119.30% | May 20, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.